TotalMarketCap

Cellyan Biotechnology

HKPDNasdaq Hong KongHealth CareOther Pharmaceuticals

Market cap

$3.354 M

$1.36 -26.49%

Close of 6 Nov 2026

As of 6 Nov 2026, Cellyan Biotechnology (HKPD) has a market capitalization of $3.35M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

16,349,986

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other Pharmaceuticals, ranked by market cap

All 10 →
  1. #6ZeroStackZSTK$56.7M
  2. #7EnerSyn GlobalESYN$46.4M
  3. #8Cosmos HealthCOSM$29.2M
  4. #9DataMeds AIMEDS$5.83M
  5. #10Cellyan BiotechnologyHKPD$3.35M

What if Cellyan Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$11,451,067

Per share 8,419,902× higher

Bitcoin $1.53T

$619,597.28

Per share 455,586× higher

Apple $5.02T

$2,034,080

Per share 1,495,647× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Cellyan Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.